SCHEMBL10095169

SCHEMBL10095169

O=C(O)CCCCCCc1cccc(CS)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.66
▸ RXFP1 Q9HBX9 1/20 0.66
▸ HDAC6 Q9UBN7 2/20 0.55
▸ HDAC3 O15379 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ ADRA1A P35348 1/20 0.55
▸ HDAC4 P56524 1/20 0.55
▸ SLC6A3 Q01959 1/20 0.55
▸ HDAC1 Q13547 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ HDAC7 Q8WUI4 1/20 0.55
▸ HDAC2 Q92769 1/20 0.55
▸ HDAC10 Q969S8 1/20 0.55
▸ HDAC11 Q96DB2 1/20 0.55
▸ HDAC8 Q9BY41 1/20 0.55
▸ HDAC9 Q9UKV0 1/20 0.55
▸ HDAC5 Q9UQL6 1/20 0.55
▸ TBXAS1 P24557 7/20 0.54
▸ LTB4R Q15722 3/20 0.51
▸ FOLH1 Q04609 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1197247 0.91 MAPT (0.78) MAPTRXFP1HDAC6HDAC3MAPK1
SCHEMBL27578485 0.85 MAPT (0.68) MAPTRXFP1HDAC6HDAC3MAPK1
SCHEMBL25342051 0.84 HDAC3 (0.76) MAPTRXFP1HDAC6HDAC3MAPK1
SCHEMBL8987510 0.83 MAPT (0.71) MAPTRXFP1HDAC6HDAC3MAPK1
SCHEMBL711512 0.83 MAPT (0.66) MAPTRXFP1HDAC11
SCHEMBL27578329 0.83 MAPT (0.66) MAPTRXFP1HDAC6HDAC3MAPK1
SCHEMBL25170050 0.83 MAPT (0.66) MAPTRXFP1HDAC6HDAC3MAPK1
SCHEMBL25173309 0.83 MAPT (0.66) MAPTRXFP1HDAC11
SCHEMBL12329336 0.83 MAPT (0.66) MAPTRXFP1HDAC6HDAC3MAPK1
SCHEMBL10095117 0.82 MAPT (0.69) MAPTRXFP1HDAC6HDAC3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124778-B2 Tricyclic inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2012-02-28 — — US disclosed
US-20100216750-A1 TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2010-08-26 — — US disclosed
WO-2008150492-A1 TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-12-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216750-A1 TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE FADS1, FAAH, SCD MAPT 3956/4885RXFP1 2442/4885HDAC6 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback